Cognizant Enhances Alnylam's IT Operations
Utilizing Cognizant's best-in-class managed services frameworks and tools, this strategic partnership focuses on augmenting Alnylam's automation efforts while minimizing operational complexities. Cognizant, a notable player in technology services, is set to serve as an essential IT Managed Services provider for Alnylam Pharmaceuticals, recognized for its pioneering role in RNA interference (RNAi) therapeutics.
Collaboration for Enhanced Business Outcomes
In this collaboration, Cognizant is tasked with managing Alnylam's global infrastructure, including operations related to cloud technology, security measures, platforms, applications, and advanced data analytics. The goal is to improve automation processes and enhance operational efficiency while ensuring transparent decision-making and cohesive performance accountability.
Expertise in Life Sciences
According to Larry Egan, Vice President of Strategic Technologies at Alnylam, "By leveraging Cognizant's know-how in the life sciences arena and innovative managed services frameworks, we aspire to improve our business outcomes and enhance customer experiences." This emphasizes the impact of their combined expertise on Alnylam’s growth.
Commitment to Innovation
Cognizant has established relationships with thirty of the top global pharmaceutical companies, aiding them in implementing advanced technological solutions. These partnerships facilitate taking innovative drugs to market, managing supply chains, manufacturing systems, and adhering to industry regulations.
Cognizant's Vision for IT Transformation
Cognizant's SVP, Mohammad Haque, expressed enthusiasm about the partnership, stating, "We are excited to partner with Alnylam on its journey toward IT transformation. Our experience with large pharmaceutical enterprises, in conjunction with our investments in AI, will empower Alnylam to reach its business objectives faster." This collaborative spirit stands at the heart of their mission to bring transformative medicines to counter rare and widespread diseases.
About Cognizant
Cognizant (Nasdaq: CTSH) is dedicated to engineering modern businesses. They aid clients in updating technology, reimagining processes, and transforming user experiences. The mission is to enable businesses to thrive in a rapidly changing environment. For more information about their services, please visit www.cognizant.com.
Contact Information
The primary contact for Cognizant is Natalie Steffen. Her focus is on fostering relationships and ensuring clients maximize their technologies effectively.
Frequently Asked Questions
What is the role of Cognizant in Alnylam's operations?
Cognizant serves as an IT Managed Services provider, focusing on enhancing Alnylam's global technology infrastructure and operational efficiency.
How will this partnership affect Alnylam's services?
This collaboration aims to improve Alnylam's automation processes, resulting in more efficient service delivery and better customer experiences.
What expertise does Cognizant bring to this collaboration?
Cognizant leverages extensive experience in the life sciences industry, equipping Alnylam with innovative technology solutions that enhance operational capabilities.
How does Cognizant ensure compliance in the pharmaceutical sector?
Cognizant collaborates with leading pharmaceutical companies to provide advanced technology solutions, helping them align with stringent industry regulations.
Where can I learn more about Cognizant's services?
For detailed information about Cognizant's offerings, you can visit their official website at www.cognizant.com.
